Joel Greenblatt acquired 292 Thousand Amedisys shares worth $28.7 Million. That's 0.23% of their equity portfolio (41st largest holding). The first Amedisys trade was made in Q4 2010. Since then Joel Greenblatt bought shares 26 more times and sold shares on seventeen occasions. The stake costed the investor $28.5 Million, netting the investor a gain of 0.7% so far.